Conivaptan

In the US, Conivaptan (conivaptan systemic) is a member of the drug class vasopressin antagonists and is used to treat Euvolemic Hyponatremia and SIADH.

US matches:

• Conivaptan


• Conivaptan Intravenous


• Conivaptan Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C03XA02

CAS registry number (Chemical Abstracts Service)

0210101-16-9

Chemical Formula

C32-H26-N4-O2

Molecular Weight

498

Therapeutic Categories

Cardiac agent

Vascular agent

Vasopressin receptor antagonist

Chemical Names

N-{4-[(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl}biphenyl-2-carboxamid (IUPAC)

(1,1'-Biphenyl)-2-carboxamide, N-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-

4''-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]-2-biphenylcarboxanilide (WHO)

Foreign Names

• Conivaptanum (Latin)
• Conivaptan (German)
• Conivaptan (French)
• Conivaptan (Spanish)

Generic Names

• YM 097 (IS: Yamanouchi)
• Conivaptan Hydrochloride (OS: USAN)
• CI-1025 (IS: Parke-Davis)
• YM 087 (IS: Yamanouchi)

Brand Name

• Vaprisol
  Astellas, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.